Sheharyar Raza: Applying AI to Accelerate Big Data Research in Transfusion Medicine
Sheharyar Raza, Transfusion Medicine Specialist and Data Scientist at University Health Network, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Big Data and AI are mutually reinforcing technologies. Organizations building either capability need to consider both.
In this article for the International Society of Blood Transfusion (ISBT) journal, co-authors Ruchika Goel, Na Li et al discuss how AI can be applied to accelerate various steps in big data research pipelines in transfusion medicine. A key takeaway is that there is substantial untapped opportunity in all aspects of big data, with significant risks well worth the effort of solving them.”
Title: Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency
Authors: Sheharyar Raza, Ruchika Goel, Christian Erikstrup, Angelo D’Alessandro, Brian Custer, Na Li
Read the Full Article on International Society of Blood Transfusion
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 25, 2026, 20:01Anand Gupta: Timing of DOAC Initiation in Newly Diagnosed Atrial Fibrillation
-
Sep 25, 2026, 19:56Steven Fein: A History of Blood Clots Doesn’t Mean a Healthy Pregnancy Is Out of Reach
-
Sep 25, 2026, 19:54Pedro Perez: “Provoked” VTE May Not Always Mean the Risk Disappears When the Provoking Event Does
-
Sep 25, 2026, 19:53Kemal Karaagac: Calcitriol May Reduce Thrombotic Risk in MASLD
-
Sep 25, 2026, 19:52The SINGLE-AF Trial Anticoagulation for Intermediate Stroke Risk – NEJM
-
Sep 25, 2026, 19:49Shinya Goto: DOAC vs Placebo in Intermediate Stroke Risk of AF in Single Country?
-
Sep 25, 2026, 19:47Bryan Cotton: DOACs Versus Nothing When Stroke Risk Is Not Zero
-
Sep 25, 2026, 19:45Selin Yaman Seval: ITP Is More Than a Low Platelet Count
-
Sep 25, 2026, 19:44Cy R. Wilkins: Treating Chemotherapy-Induced Thrombocytopenia Beyond the Platelet Count